Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS (2022) CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2015–2019. Neurooncology 24:v1–v95. https://doi.org/10.1093/neuonc/noac202
Hijiya N, Hudson MM, Lensing S, Zacher M, Onciu M, Behm FG, Razzouk BI, Ribeiro RC, Rubnitz JE, Sandlund JT, Rivera GK, Evans WE, Relling MV, Pui CH (2007) Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA 297:1207–1215. https://doi.org/10.1001/jama.297.11.1207
Article CAS PubMed Google Scholar
Preston DL, Ron E, Yonehara S, Kobuke T, Fujii H, Kishikawa M, Tokunaga M, Tokuoka S, Mabuchi K (2002) Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 94:1555–1563. https://doi.org/10.1093/jnci/94.20.1555
Article CAS PubMed Google Scholar
Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99:307–314. https://doi.org/10.1007/s11060-010-0386-3
Article PubMed PubMed Central Google Scholar
Claus EB, Black PM, Bondy ML, Calvocoressi L, Schildkraut JM, Wiemels JL, Wrensch M (2007) Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer 110:471–476. https://doi.org/10.1002/cncr.22783
Vadivelu S, Sharer L, Schulder M (2010) Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy. J Neurosurg 112:920–924. https://doi.org/10.3171/2009.8.JNS09201
Article CAS PubMed Google Scholar
Patnaik A, Pattnaik N, Sekar A, Singh DK (2023) Meningioma getting a common presentation in uncommon Cowden syndrome: a case report. J Neurosci Rural Pract 14:756–758. https://doi.org/10.25259/JNRP_305_2023
Article PubMed PubMed Central Google Scholar
Papi L, De Vitis LR, Vitelli F, Ammannati F, Mennonna P, Montali E, Bigozzi U (1995) Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet 95:347–351. https://doi.org/10.1007/BF00225206
Article CAS PubMed Google Scholar
Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DC, Preusser M, Minniti G, Lund-Johansen M, Lefranc F, Houdart E, Sallabanda K, Le Rhun E, Nieuwenhuizen D, Tabatabai G, Soffietti R, Weller M (2021) EANO guideline on the diagnosis and management of meningiomas. Neurooncology 23:1821–1834. https://doi.org/10.1093/neuonc/noab150
Marchetti M, Sahgal A, De Salles AAF, Levivier M, Ma L, Paddick I, Pollock BE, Regis J, Sheehan J, Suh JH, Yomo S, Fariselli L (2020) Stereotactic radiosurgery for Intracranial Noncavernous Sinus Benign Meningioma: International Stereotactic Radiosurgery Society Systematic Review, Meta-Analysis and Practice Guideline. Neurosurgery 87(5):879–890. https://doi.org/10.1093/neuros/nyaa169
Article PubMed PubMed Central Google Scholar
Harrison G, Kano H, Lunsford LD, Flickinger JC, Kondziolka D (2016) Quantitative tumor volumetric responses after Gamma Knife radiosurgery for meningiomas. J Neurosurg 124:146–154. https://doi.org/10.3171/2014.12.JNS141341
Hall JT, Opalak CF, Carr MT, Harris TJ, Broaddus WC (2021) The Effect of Radiation on Meningioma volume change. World Neurosurg 153:e141–e146. https://doi.org/10.1016/j.wneu.2021.06.080
Fega KR, Fletcher GP, Waddle MR, Peterson JL, Ashman JB, Barrs DM, Bendok BR, Patel NP, Porter AB, Vora SA (2019) Analysis of MRI volumetric changes after Hypofractionated Stereotactic Radiation Therapy for Benign Intracranial neoplasms. Adv Radiation Oncol 4:43–49. https://doi.org/10.1016/j.adro.2018.08.013
Chen WC, Hara J, Magill ST, Wu A, Aghi MK, Theodosopoulos PV, Perry A, McDermott MW, Sneed PK, Raleigh DR, Braunstein SE (2018) Salvage therapy outcomes for atypical meningioma. J Neurooncol 138:425–433. https://doi.org/10.1007/s11060-018-2813-9
Choi CY, Soltys SG, Gibbs IC, Harsh GR, Jackson PS, Lieberson RE, Chang SD, Adler JR (2010) Cyberknife stereotactic radiosurgery for treatment of atypical (WHO grade II) cranial meningiomas. Neurosurgery 67:1180–1188. https://doi.org/10.1227/NEU.0b013e3181f2f427
Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL (2012) Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience. Cancer 118:1048–1054. https://doi.org/10.1002/cncr.26362
Kano H, Takahashi JA, Katsuki T, Araki N, Oya N, Hiraoka M, Hashimoto N (2007) Stereotactic radiosurgery for atypical and anaplastic meningiomas. J Neurooncol 84:41–47. https://doi.org/10.1007/s11060-007-9338-y
Aboukais R, Zairi F, Lejeune JP, Le Rhun E, Vermandel M, Blond S, Devos P, Reyns N (2015) Grade 2 meningioma and radiosurgery. J Neurosurg 122:1157–1162. https://doi.org/10.3171/2014.9.Jns14233
Pasquier D, Bijmolt S, Veninga T, Rezvoy N, Villa S, Krengli M, Weber DC, Baumert BG, Canyilmaz E, Yalman D, Szutowicz E, Tzuk-Shina T, Mirimanoff RO, Rare Cancer N (2008) Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys 71:1388–1393. https://doi.org/10.1016/j.ijrobp.2007.12.020
Hug EB, Devries A, Thornton AF, Munzenride JE, Pardo FS, Hedley-Whyte ET, Bussiere MR, Ojemann R (2000) Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol 48:151–160. https://doi.org/10.1023/a:1006434124794
Article CAS PubMed Google Scholar
Momin AA, Shao J, Soni P, Almeida JP, Suh JH, Murphy ES, Chao ST, Angelov L, Mohammadi AM, Barnett GH, Recinos PF, Kshettry VR (2021) Outcomes of salvage radiation for recurrent world health organization grade II meningiomas: a retrospective cohort study. J Neurooncol 152:373–382. https://doi.org/10.1007/s11060-021-03711-z
Rogers CL, Pugh SL, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Barani IJ, Braunstein S, Bovi JA, de Groot JF, Whitton AC, Lindhorst SM, Deb N, Shrieve DC, Shu HK, Bloom B, Machtay M, Mishra MV, Robinson CG, Won M, Mehta MP (2023) Low-risk meningioma: initial outcomes from NRG Oncology/RTOG 0539. Neurooncology 25:137–145. https://doi.org/10.1093/neuonc/noac137
Milosevic MF, Frost PJ, Laperriere NJ, Wong CS, Simpson WJ (1996) Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 34:817–822. https://doi.org/10.1016/0360-3016(95)02166-3
Article CAS PubMed Google Scholar
Huang RX, Zhou PK (2020) DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther 5:60. https://doi.org/10.1038/s41392-020-0150-x
Article CAS PubMed PubMed Central Google Scholar
Theys J, Jutten B, Habets R, Paesmans K, Groot AJ, Lambin P, Wouters BG, Lammering G, Vooijs M (2011) E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells. Radiotherapy Oncology: J Eur Soc Therapeutic Radiol Oncol 99:392–397. https://doi.org/10.1016/j.radonc.2011.05.044
Pawlik TM, Keyomarsi K (2004) Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59:928–942. https://doi.org/10.1016/j.ijrobp.2004.03.005
Alkotub B, Bauer L, Bashiri Dezfouli A, Hachani K, Ntziachristos V, Multhoff G, Kafshgari MH (2024) Radiosensitizing capacity of fenofibrate in glioblastoma cells depends on lipid metabolism. Redox Biol 79:103452. https://doi.org/10.1016/j.redox.2024.103452
Article CAS PubMed PubMed Central Google Scholar
Pasqualetti F, Miniati M, Gonnelli A, Gadducci G, Giannini N, Palagini L, Mancino M, Fuentes T, Paiar F (2023) Cancer Stem cells and Glioblastoma: time for innovative biomarkers of Radio-Resistance? Biology (Basel) 12. https://doi.org/10.3390/biology12101295
Dewhirst MW, Cao Y, Moeller B (2008) Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 8:425–437. https://doi.org/10.1038/nrc2397
Comments (0)